Nonprofit · EIN 85-1085804
PHARE BIO INC
Tax-exempt · BOSTON, MA 02210
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| June 30, 2025 | 990 | $5,476,072 | $4,787,029 | $689,043 | $7,089,770 | $3,860,128 | $3,229,642 |
| June 30, 2024 | 990 | $2,148,132 | $1,461,003 | $687,129 | $2,586,256 | $76,903 | $2,509,353 |
| June 30, 2023 | 990 | $2,009,513 | $1,249,510 | $760,003 | $1,837,494 | $88,135 | $1,749,359 |
Financial details: 990 for the year ended June 30, 2025
Revenue
- Contributions, gifts and grants
- $2,386,024
- Program service revenue
- $2,993,066
- Investment income
- $96,982
- Other revenue
- $0
Expenses
- Grants and similar amounts paid
- $0
- Compensation of officers, directors and key employees
- $669,618
- Other salaries and wages
- $681,728
- Salaries, compensation and benefits (total)
- $1,475,636
- Professional fundraising fees
- $35,000
- Legal fees
- $64,186
- Accounting fees
- $131,198
- Occupancy
- $32,802
- Travel
- $32,757
- Program services (functional)
- $4,047,704
- Management and general (functional)
- $546,706
- Fundraising (functional)
- $192,619
Balance sheet and other
- Total assets, start of year
- $2,586,256
- Total assets, end of year
- $7,089,770
- Total liabilities, end of year
- $3,860,128
- Net assets, end of year
- $3,229,642
- Land, buildings and equipment
- $14,617
- Publicly traded securities
- $4,239,896
- Net assets without donor restrictions
- $3,229,642
- Gross receipts
- $5,476,072
- Employees
- 3
- Volunteers
- 7
- Year formed
- 2020
- State of legal domicile
- MA
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended June 30, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| AKHILA KOSARAJU | CEO & PRESIDENT Trustee or director, Officer | 40 | $584,833 | $23,055 |
| CLAIRE NISHIOKA ROBINSON | SENIOR DIRECTOR, BUSINESS STRATEGIES Highest-paid employee | 40 | $243,333 | $12,105 |
| LEANNE MINALL | HEAD OF SCIENCE Highest-paid employee | 40 | $158,125 | $4,069 |
| WILLIAM FOSTER | CHAIR & TREASURER Trustee or director, Officer | 1 | $0 | $0 |
| STEVE ELLIS | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JAMES COLLINS | DIRECTOR (UNTIL 12/24) Trustee or director | 1 | $0 | $0 |
| JOSE-CARLOS GUTTIEREZ-RAMOS | DIRECTOR Trustee or director | 1 | $0 | $0 |
| ROBERT PLENGE | DIRECTOR Trustee or director | 1 | $0 | $0 |
| SUSAN URAHN | DIRECTOR Trustee or director | 1 | $0 | $0 |
| SETH BERKELY | DIRECTOR Trustee or director | 1 | $0 | $0 |
990 for the year ended June 30, 2024: 8 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| AKHILA KOSARAJU | CEO & PRESIDENT Trustee or director, Officer | 40 | $549,218 | $14,184 |
| CLAIRE NISHIOKA ROBINSON | SENIOR DIRECTOR, BUSINESS STRATEGIES Highest-paid employee | 40 | $159,583 | $7,634 |
| WILLIAM FOSTER | CHAIR & TREASURER Trustee or director, Officer | 1 | $0 | $0 |
| STEVE ELLIS | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JAMES COLLINS | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JOSE-CARLOS GUTTIEREZ-RAMOS | DIRECTOR Trustee or director | 1 | $0 | $0 |
| ROBERT PLENGE | DIRECTOR Trustee or director | 1 | $0 | $0 |
| SUSAN URAHN | DIRECTOR Trustee or director | 1 | $0 | $0 |
990 for the year ended June 30, 2023: 7 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| AKHILA KOSARAJU | CEO & PRESIDENT Trustee or director, Officer | 40 | $531,282 | $20,500 |
| WILLIAM FOSTER | CHAIR & TREASURER Trustee or director, Officer | 1 | $0 | $0 |
| STEVE ELLIS | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JAMES COLLINS | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JOSE-CARLOS GUTTIEREZ-RAMOS | DIRECTOR Trustee or director | 1 | $0 | $0 |
| ROBERT PLENGE | DIRECTOR Trustee or director | 1 | $0 | $0 |
| SUSAN URAHN | DIRECTOR Trustee or director | 1 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 303 CONGRESS STREET SECOND FLOOR, BOSTON, MA 02210-1007
- In care of
- % CASNER & EDWARDS LLP
- Principal officer (990 for 2024)
- AKHILA KOSARAJU, 303 CONGRESS STREET 2ND FLOOR, BOSTON, MA 02210
- Signed the 990
- AKHILA KOSARAJU, CEO AND PRESIDENT
- Phone
- (617) 426-5900
- Website
- WWW.PHAREBIO.ORG
- Return prepared by
- CLIFTONLARSONALLEN LLP
Mission
PHARE BIO'S MISSION IS TO DEVELOP CRITICALLY NEEDED ANTIBIOTICS TO ADDRESS A LOOMING CRISIS IN ANTIBIOTIC RESISTANCE. USING NOVEL AI AND DEEP LEARNING APPROACHES, PHARE BIO AIMS TO RAPIDLY DISCOVER AND DEVELOP NEW CLASSES OF ANTIBIOTICS AGAINST THE DEADLIEST PATHOGENS, AND ENSURE THAT THESE THERAPIES REACH THE PATIENTS IN GREATEST NEED.
Program accomplishments
- PHARE BIO'S PROGRAM MANDATE IS TO DEVELOP CRITICALLY NEEDED ANTIBIOTICS TO ADDRESS A LOOMING CRISIS IN ANTIBIOTIC RESISTANCE. PHARE BIO HAS A NUMBER OF PROMISING EARLY-STAGE PIPELINE PROJECTS AND IS CONDUCTING EXTENSIVE IN VITRO AND IN VIVO DRUG DEVELOPMENT STUDIES TO ADVANCE POTENTIAL ANTIBIOTICS THROUGH THE RESEARCH AND DEVELOPMENT PROCESS. THESE ANTIBIOTIC CANDIDATES ARE DISCOVERED USING NOVEL AI/DEEP LEARNING METHODOLOGIES PIONEERED BY PROFESSOR JIM COLLINS' LAB AT MIT (PHARE BIO'S CO-FOUNDER), AND ARE DEVELOPED AND OPTIMIZED BY PHARE BIO FOR FUTURE CLINICAL APPLICATION. WITH THIS CUTTING-EDGE PLATFORM AND A NONPROFIT BUSINESS MODEL, PHARE BIO IS DEVELOPING NEW CLASSES OF ANTIBIOTICS AND UNIQUELY ADDRESSING ECONOMIC CHALLENGES FACING THE ANTIBIOTIC MARKET. IN THIS PAST YEAR, PHARE BIO DISCOVERED AND STUDIED ADDITIONAL NOVEL ANTIBIOTICS WITH ITS GENERATIVE AI DRUG DESIGN PLATFORM, FURTHER ADVANCING ITS EARLY-STAGE PIPELINE.Expenses $4,047,704 · revenue $2,993,066
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in June, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | June 30, 2026 | November 16, 2026 | Not due yet |
| 2024 | June 30, 2025 | November 17, 2025 | 990 on file |
| 2023 | June 30, 2024 | November 15, 2024 | 990 on file |
IRS record
- EIN
- 85-1085804
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2020
- Accounting year ends
- June
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Medical research (H99)
- Assets (IRS master file)
- $7,089,770
- Income (IRS master file)
- $5,476,072
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | June 2025 | $5,476,072 | $4,787,029 | $7,089,770 | IRS |
| 990 | June 2024 | $2,148,132 | $1,461,003 | $2,586,256 | XML |
| 990 | June 2023 | $2,009,513 | $1,249,510 | $1,837,494 | XML |
| 990 | June 2022 | $1,558,823 | $1,178,664 | $1,009,435 | IRS |
| 990 | June 2021 | – | – | – | IRS |
| 990-EZ | June 2020 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 85-1085804).
Questions about PHARE BIO INC
- What is the EIN of PHARE BIO INC?
- The employer identification number (EIN) of PHARE BIO INC is 85-1085804.
- Is PHARE BIO INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2020.
- Are donations to PHARE BIO INC tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does PHARE BIO INC file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of PHARE BIO INC due?
- The return for tax year 2025 (the year ending June 30, 2026) is due November 16, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did PHARE BIO INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended June 2025.
- Who is the principal officer of PHARE BIO INC?
- The 990 for the year ended June 30, 2025 names AKHILA KOSARAJU.
- Who are the officers and directors of PHARE BIO INC?
- The 990 for the year ended June 30, 2025 lists 10 people; 3 received compensation from the organization, the highest $584,833 (AKHILA KOSARAJU, CEO & PRESIDENT).
- How much revenue does PHARE BIO INC have?
- On its 990 for the year ended June 30, 2025 it reported revenue of $5,476,072, expenses of $4,787,029 and total assets of $7,089,770 at year end.
Other nonprofits in BOSTON
- DANA-FARBER CANCER INSTITUTE EIN 04-2263040 · last filed 990 for 2025
- DANA FARBER MASS GENERAL BRIGHAM CANCER CARE INC EIN 04-3320640 · last filed 990 for 2025
- BAIM INSTITUTE FOR CLINICAL RESEARCH INC EIN 04-3521077 · last filed 990 for 2025
- BOSTON VA RESEARCH INSTITUTE INC EIN 04-3081524 · last filed 990 for 2025
- CENTER FOR INFORMATION AND STUDY ON CLINICAL RESEARCH PARTICIPATION EIN 20-0588190 · last filed 990 for 2025
- HEALTH EFFECTS INSTITUTE EIN 04-2708045 · last filed 990 for 2025
- INSTITUTE FOR PROTEIN INNOVATION INC EIN 81-3250208 · last filed 990 for 2025
- DIGITAL MEDICINE SOCIETY INC EIN 83-4205470 · last filed 990 for 2024